News and Announcements
Alcidion’s CMO to Present at Health Informatics Conference
- Published July 05, 2016 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
1st July 2016, ASX Announcement
Highlights:
- Professor Malcolm Pradhan to present at Health Informatics Conference.
- Alcidion to unveil “Deep Learning” Product Roadmap Strategy for Patient Flow.
- Technology incorporates predictive analytics to streamline Patient Flow.
Alcidion Group Limited (ASX:ALC) is pleased to announce that Professor Malcolm Pradhan, Alcidion’s Chief Medical Officer, will present a paper on “Deep Learning for Patient Flow Prediction” at the Health Informatics Conference (HIC) on July 25th 2016.
Deep learning is a branch of Machine Learning based on recent advances in neural network technology that has enabled computers to achieve better than human performance in tasks such as image recognition.
To view the full announcement, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
